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Abstract: A new xenicane diterpenoid, 15-deoxy-isoxeniolide-A (1) along with 
four known compounds 9-deoxy-isoxeniolide-A (2), isoxeniolide-A (3), 
xeniolide-A (4) and coraxeniolide-B (5) were isolated from the Bornean soft coral 
Xenia sp. The structure of this metabolite was elucidated on the basis of spectral 
analysis NMR and HRESIMS. Compound 5 showed potent cytotoxic activity 
against ATL cell line, S1T. 
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Table S1. 
13
C and 
1
H NMR (600 and 150 MHz) data of 1 (CDCl3,  in ppm, J in Hz). 
No 
1 
C H 
1 71.0 (t) 4.06 dd (11.7, 5.8, -H) 
 
 3.63 t (11.7, -H) 
3 169.2 (s)  
4 130.4 (s)  
a 50.9 (d) 2.57 dt (8.9, 3.4) 
5 37.9 (t) 1.61-1.63 m 
6 39.8 (t) 2.16-2.18 m 
7 132.9 (s)  
8 130.4 (d) 5.20 d (6.9) 
9 67.1 (d) 4.77 t (6.9) 
 45.6 (t) 2.44 dd (13.8, 6.9, -H) 

 2.39 d (13.8, -H) 
11 147.9 (s)  
a 50.0 (d) 1.99 ddd (11.7, 5.8, 3.4) 
12 137.4 (d) 6.33 d (11.0) 
13 123.4 (d) 6.67 dd (15.8, 11.0) 
14 149.2 (d) 5.92 dd (15.8, 6.9) 
15 31.5 (d) 2.41 m 
16 22.0 (q) 1.04 d (6.9) 
17 22.0 (q) 1.03 d (6.9) 
18 17.3 (q) 1.69 s 
19 114.7 (t) 5.06 s 
 
 4.96 s 
 
 
 
 
 
 
 
  
Table S2. Cytotoxicity of compounds 1-5. 
Compound 
Cell line IC50 (µg/mL) 
S1T 
1 49.75 
2 40.25 
3 46.07 
4 34.75 
5 4.12 
 
Figure S2. COSY, selective HMBC and NOE correlations of 1. 
 
 
 
 
Figure S3. 1H NMR spectrum of 15-deoxy-isoxeniolide-A (1) in CDCl3 (600 MHz). 
 
Figure S4. 13C NMR spectrum of 15-deoxy-isoxeniolide-A (1) in CDCl3 (150 MHz). 
 
Figure S5. HSQC spectrum of 15-deoxy-isoxeniolide-A (1) in CDCl3. 
 
Figure S6. 1H-1H COSY spectrum of 15-deoxy-isoxeniolide-A (1) in CDCl3. 
 
Figure S7. HMBC spectrum of 15-deoxy-isoxeniolide-A (1) in CDCl3. 
 
Figure S8. NOESY spectrum of 15-deoxy-isoxeniolide-A (1) in CDCl3. 
 
Figure S9. HRESIMS spectrum of 15-deoxy-isoxeniolide-A (1). 
 
 
 
